Utilization of intravenous thrombolysis is increasing in the United States
Therapies Monday, August 20th, 2012Onlinelibrary.wiley.com: 8/9/12.
valuating recombinant tissue plasminogen activator utilization rates is important, as many studies have demonstrated that administration of recombinant tissue plasminogen activator to qualified patients significantly improves prognosis.
Aims
We investigated recent trends in the utilization and outcomes of administration of intravenous recombinant tissue plasminogen activator in the United States using the National Inpatient Sample between 2001 and 2008. Read More
